The CD40 Kozak SNP: a new susceptibility loci for Graves' disease?

The CD40 Kozak SNP: a new susceptibility loci for Graves' disease?

Bibliographic Details
Main Authors:	Simmonds, M, Heward, J, Franklyn, J, Gough, S
Format:	Journal article
Language:	English
Published:	2005

Similar Items

A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians.
by: Heward, J, et al.
Published: (2004)

Tag SNP screening of the PDCD1 gene for association with Graves' disease.
by: Newby, P, et al.
Published: (2007)

Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study.
by: Newby, P, et al.
Published: (2010)

Sharing of susceptibility loci between autoimmune diseases: lack of association of the insulin gene region with Graves' disease.
by: Allahabadia, A, et al.
Published: (1999)

IL-13 and chromosome 5q31-q33: problems of identifying association within regions of linkage to Graves' disease.
by: Simmonds, M, et al.
Published: (2005)

Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.
by: Simmonds, M, et al.
Published: (2006)

A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease.
by: Simmonds, M, et al.
Published: (2004)

Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
by: Zeitlin, A, et al.
Published: (2006)

Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.
by: Syed, A, et al.
Published: (2007)

Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.
by: Simmonds, M, et al.
Published: (2006)

Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease.
by: Zeitlin, A, et al.
Published: (2008)

A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect.
by: Simmonds, M, et al.
Published: (2007)

Association of PTPN22 haplotypes with Graves' disease.
by: Heward, J, et al.
Published: (2007)

Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.
by: Yesmin, K, et al.
Published: (2010)

No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom.
by: Heward, J, et al.
Published: (2001)

Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians.
by: Collins, J, et al.
Published: (2004)

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.
by: Brand, O, et al.
Published: (2007)

Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK.
by: Tait, K, et al.
Published: (2004)

A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al.
by: Simmonds, M, et al.
Published: (2002)

Regression mapping of association between the human leukocyte antigen region and Graves disease.
by: Simmonds, M, et al.
Published: (2005)

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
by: Allahabadia, A, et al.
Published: (2001)

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
by: Harper, L, et al.
Published: (2004)

Genetic susceptibility to the development of autoimmune disease.
by: Heward, J, et al.
Published: (1997)

Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3.
by: Simmonds, M, et al.
Published: (2010)

Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease.
by: Simmonds, M, et al.
Published: (2010)

Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.
by: Heward, J, et al.
Published: (1999)

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.
by: Brand, O, et al.
Published: (2009)

Seven newly identified loci for autoimmune thyroid disease.
by: Cooper, J, et al.
Published: (2012)

The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.
by: Heward, J, et al.
Published: (1999)

Gisela Kozak Rovero: la reinvención de Caracas
by: Inma Chacón
Published: (2009-06-01)

Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies.
by: Allahabadia, A, et al.
Published: (1998)

A machine learning-based SNP-set analysis approach for identifying disease-associated susceptibility loci
by: Princess P. Silva, et al.
Published: (2022-09-01)

Review of “Enacting musical time. The bodily experience of new music,” by Mariusz Kozak
by: Andrea Schiavio
Published: (2021-06-01)

Correction: Author Correction: Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis
by: Xianbo Zuo, et al.
Published: (2018-03-01)

High-density SNP association study of the autism susceptibility loci on chromosome 7q
by: Sykes, N, et al.
Published: (2006)

The immunogenetics of Graves' disease
by: Gough, S
Published: (1999)

The genetics of Graves' disease.
by: Gough, S
Published: (2000)

Natural variability of Kozak sequences correlates with function in a zebrafish model.
by: Steven J Grzegorski, et al.
Published: (2014-01-01)

Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease
by: Kotb Abbass Metwalley, et al.
Published: (2020-06-01)

Age and gender predict the outcome of treatment for Graves' hyperthyroidism.
by: Allahabadia, A, et al.
Published: (2000)